R6	Coref Anaphora:T33 Antecedent:T34
R7	Coref Anaphora:T39 Antecedent:T47
T48	SPAN 834 858	c-Myc, Bcl-2, and Bcl-xL
R8	Coref Anaphora:T41 Antecedent:T48
T1	Protein 0 4	IL-7
T2	Protein 39 44	v-Abl
T3	Protein 141 146	v-Abl
T4	Protein 224 228	IL-4
T5	Protein 233 237	IL-7
T6	Protein 287 314	Janus protein kinase (JAK)1
T7	Protein 316 320	JAK3
T8	Protein 333 338	STAT6
T9	Protein 370 375	v-Abl
T10	Protein 449 454	v-Abl
T11	Protein 552 556	IL-4
T12	Protein 561 565	IL-7
T13	Protein 622 627	v-Abl
T14	Protein 658 662	IL-4
T15	Protein 688 692	IL-7
T16	Protein 785 789	IL-7
T17	Protein 834 839	c-Myc
T18	Protein 841 846	Bcl-2
T19	Protein 852 858	Bcl-xL
T20	Protein 906 910	IL-7
T21	Protein 928 933	v-Abl
T22	Protein 1058 1062	IL-7
T23	Protein 1108 1112	IL-7
T24	Protein 1153 1158	v-Abl
T25	Protein 1201 1205	IL-4
T26	Protein 1210 1214	IL-7
T27	Protein 1257 1262	v-Abl
T47	Exp 724 741	cell cycle arrest
T33	Exp 83 88	which
T34	Exp 66 79	The mechanism
T35	Exp 471 490	the cellular events
T36	Exp 502 535	the Abelson murine leukemia virus
T37	Exp 537 548	the effects
T38	Exp 412 445	these cytokine signaling pathways
T39	Exp 742 746	that
T40	Exp 706 719	the apoptosis
T41	Exp 859 863	that
T42	Exp 803 816	the decreases
T43	Exp 820 830	the levels
T44	Exp 969 984	the pre-B cells
T45	Exp 1179 1183	that
T46	Exp 1064 1077	These results
